Home » Topics » BioWorld Science

BioWorld Science
RSS

For pain signaling, endocytosis is not the end

Feb. 9, 2022

SENS-401 shows good local bioavailability in sensorineural hearing loss model

Feb. 9, 2022

Xanadu signs agreements with Yale to support development of intranasal SARS-CoV-2 vaccine booster

Feb. 9, 2022

Immunome's antibody cocktail effective against live versions of SARS-CoV-2 Omicron variant in vitro

Feb. 9, 2022

MDL-001 significantly reduces SARS-CoV-2 viral load in lungs in preclinical study

Feb. 9, 2022

Eisai divulges new OX2 receptor agonists for narcolepsy

Feb. 9, 2022

Caregen identifies new antivirals for SARS-CoV-2

Feb. 9, 2022

Korean researchers synthesize PDE5A and HDAC6 dual inhibitors for Alzheimer's

Feb. 9, 2022

Nanjing Zhengxiang Pharmaceuticals divulges DHODH inhibitors

Feb. 9, 2022

IFM Due patents hSTING antagonists for cancer

Feb. 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...